Lobular Carcinoma in SITU (LCIS): Symptoms, Causes, Diagnosis, and Treatment

Lobules are glands in the body that produce breast milk. Lobular carcinoma in SITU (LCIS) loses the ability to produce adequate breast milk, due to the presence of strange cells in the lobules. Contrary to popular opinion, LCIS is not breast cancer. However, people with the condition are more likely to have breast cancer. It is a rare illness, so it is important to get properly diagnosed by your healthcare provider. It would help to know that the abnormal cells seen in the lobules are usually in SITU, that is to say, they have not moved to other tissues around the breast. According to experts, people with lobular carcinoma in SITU are 10 times more susceptible to breast cancer than people who do not have the condition.

In this article, we will be discussing the symptoms, causes, diagnosis, treatment and other important things to note about lobular carcinoma in SITU.

Is Lobular Carcinoma in SITU A Common Condition?

According to experts, lobular carcinoma in SITU (LCIS) is a rare disease. Research shows that the condition can be observed in 5-11 women per 100,000 people. The condition is more common in women than in men. Studies show that one in 100,000 men. Also, 2 percent of breast cancer in men is caused by LCIS.

According to research, lobular carcinoma in SITU is more common in people between the ages of 40 and 60.